CytoMed Increase Worldwide Product Potential With New Collaborations

8 September 1996

CytoMed Increases Worldwide Product Potential With New Collaborations

Chiron has made an additional equity investment in CytoMed as a milestone payment for its achievement in the joint collaboration between the two companies for the development and commercialization of complement inhibitors which was first started in 1994.

Chiron has also agreed to continue funding CytoMed's research and development activities, which have so far produced encouraging results in the field of novel molecules for inflammatory disease. Chiron is responsible for the clinical development and manufacturing of CMI-CAB-2 for the treatment of inflammation and other complement inhibitors, while CytoMed has US co-promotion rights for compounds resulting from the collaboration.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight